First generic version of new Pfizer COVID-19 pill enters Bangladeshi pharmacies
- In trials, Paxlovid reduced the risk of COVID-19-related hospitalization and death by 89 percent
- Pfizer’s treatment is protected by patents, but least-developed countries such as Bangladesh are not bound by them